The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging
Abstract
Ferumoxides, dextran‐coated superparamagnetic iron oxide (SPIO) particles, form ferumoxide–transfection agent (FE–TA) complexes that are internalized into endosomes/lysosomes and have been used to label cells for in vivo MRI tracking and localization studies. A better understanding of the physical state of the FE–TA complexes during endocytosis could improve their use. The purpose of this study was to measure the rate of the degradation of iron particles under varying physiological conditions. FE–TA complexes were incubated in seven different buffers containing different chelates with different pH. Reducible iron concentrations, T2 relaxation rates and gradient echo (GRE) magnetic resonance images (MRI) were obtained from each condition immediately after incubation and at 6, 24, 48, 72 and 96 h and days 7, 14 and 21. The dynamics of FE–TA in the endosome/lysomes within the cells were visualized with electron microscopy. Sodium citrate buffer at pH 4.5 rapidly dissolved FE–TA complexes. However, FE–TA complexes were less soluble in the same buffer at pH 5.5. Similarly, FE–TA complexes were not readily soluble in any of the other buffers with or without chelates, regardless of pH. Electron microscopic images showed degraded FE–TA in some intracellular endosome/lysosomes between days 3 and 5. In the cellular environment, some of the FE–TA‐containing endosomes were found to fuse with lysosomes, causing rapid dissociation at low pH and exposing the iron core to chelates that resulted in soluble Fe(III) within the lysosomes. The studies presented represent a first step in identifying the important cellular environmental parameters affecting the integrity of FE–TA complexes. Published in 2005 by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Superparamagnetic iron oxide: pharmacokinetics and toxicity
Weissleder, R., Stark, D., Engelstad, B., Bacon, B., Compton, C., White, D., Jacobs, P., & Lewis, J. (1989) · American Journal of Roentgenology · doi:10.2214/ajr.152.1.167 · Cited by 1,045
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
Richardson, D. R., & Ponka, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00014-7 · Cited by 704
Frank, J. A., Miller, B. R., Arbab, A. S., Zywicke, H. A., Jordan, E. K., Lewis, B. K., Bryant, L. H., & Bulte, J. W. M. (2003) · Radiology · doi:10.1148/radiol.2281020638 · Cited by 643
Self-citationArbab, A. S., Bashaw, L. A., Miller, B. R., Jordan, E. K., Lewis, B. K., Kalish, H., & Frank, J. A. (2003) · Radiology · doi:10.1148/radiol.2293021215 · Cited by 552
Self-citationArosio, P., & Levi, S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00842-0 · Cited by 542
Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells
Crichton, R. R., Wilmet, S., Legssyer, R., & Ward, R. J. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00461-0 · Cited by 495
Iron metabolism, free radicals, and oxidative injury
Emerit, J., Beaumont, C., & Trivin, F. (2001) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00068-3 · Cited by 456
Aisen, P., Wessling-Resnick, M., & Leibold, E. A. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80033-7 · Cited by 427
Raynal, I., Prigent, P., Peyramaure, S., Najid, A., Rebuzzi, C., & Corot, C. (2004) · Investigative Radiology · doi:10.1097/01.rli.0000101027.57021.28 · Cited by 403
Schlabach, M., & Bates, G. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41699-2 · Cited by 284
Cited by
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., & Medintz, I. L. (2013) · Chemical Reviews · doi:10.1021/cr300143v · Cited by 1,423
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
Wahajuddin, & Arora (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30320 · Cited by 1,117
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
Singh, N., Jenkins, G. J. S., Asadi, R., & Doak, S. H. (2010) · Nano Reviews · doi:10.3402/nano.v1i0.5358 · Cited by 1,112
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
Arami, H., Khandhar, A., Liggitt, D., & Krishnan, K. M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00541h · Cited by 830
Soenen, S. J., Rivera-Gil, P., Montenegro, J.-M., Parak, W. J., De Smedt, S. C., & Braeckmans, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.08.001 · Cited by 699
Pure and multi metal oxide nanoparticles: synthesis, antibacterial and cytotoxic properties
Stankic, S., Suman, S., Haque, F., & Vidic, J. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0225-6 · Cited by 678
Bacterial adherence and biofilm formation on medical implants: A review
Veerachamy, S., Yarlagadda, T., Manivasagam, G., & Yarlagadda, P. K. (2014) · Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine · doi:10.1177/0954411914556137 · Cited by 583
Soenen, S. J., Parak, W. J., Rejman, J., & Manshian, B. (2015) · Chemical Reviews · doi:10.1021/cr400714j · Cited by 515
A general mechanism for intracellular toxicity of metal-containing nanoparticles
Sabella, S., Carney, R. P., Brunetti, V., Malvindi, M. A., Al-Juffali, N., Vecchio, G., Janes, S. M., Bakr, O. M., Cingolani, R., Stellacci, F., et al. (2014) · Nanoscale · doi:10.1039/c4nr01234h · Cited by 467
Nanozyme for tumor therapy: Surface modification matters
Tang, G., He, J., Liu, J., Yan, X., & Fan, K. (2021) · Exploration · doi:10.1002/exp.20210005 · Cited by 441
In vivo degeneration and the fate of inorganic nanoparticles
Feliu, N., Docter, D., Heine, M., del Pino, P., Ashraf, S., Kolosnjaj-Tabi, J., Macchiarini, P., Nielsen, P., Alloyeau, D., Gazeau, F., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00699f · Cited by 423
Physiologically Based Pharmacokinetic Modeling of Nanoparticles
Li, M., Al-Jamal, K. T., Kostarelos, K., & Reineke, J. (2010) · ACS Nano · doi:10.1021/nn1018818 · Cited by 351
Universal cell labelling with anionic magnetic nanoparticles
Wilhelm, C., & Gazeau, F. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.016 · Cited by 343
Huang, D.-M., Hsiao, J.-K., Chen, Y.-C., Chien, L.-Y., Yao, M., Chen, Y.-K., Ko, B.-S., Hsu, S.-C., Tai, L.-A., Cheng, H.-Y., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.032 · Cited by 337
Huang, G., Chen, H., Dong, Y., Luo, X., Yu, H., Moore, Z., Bey, E. A., Boothman, D. A., & Gao, J. (2013) · Theranostics · doi:10.7150/thno.5411 · Cited by 318
Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling
Soenen, S. J. H., Himmelreich, U., Nuytten, N., & De Cuyper, M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.075 · Cited by 302
Cell Uptake and in Vitro Toxicity of Magnetic Nanoparticles Suitable for Drug Delivery
Häfeli, U. O., Riffle, J. S., Harris-Shekhawat, L., Carmichael-Baranauskas, A., Mark, F., Dailey, J. P., & Bardenstein, D. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900083m · Cited by 277
Biodegradation of Iron Oxide Nanocubes: High-Resolution In Situ Monitoring
Lartigue, L., Alloyeau, D., Kolosnjaj-Tabi, J., Javed, Y., Guardia, P., Riedinger, A., Péchoux, C., Pellegrino, T., Wilhelm, C., & Gazeau, F. (2013) · ACS Nano · doi:10.1021/nn305719y · Cited by 274
Reducing infections through nanotechnology and nanoparticles
Webster, T. J., & Taylor (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s22021 · Cited by 267
Tracking stem cells using magnetic nanoparticles
Cromer Berman, S. M., Walczak, P., & Bulte, J. W. M. (2011) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.140 · Cited by 265
Soenen, S. J. H., Nuytten, N., De Meyer, S. F., De Smedt, S. C., & De Cuyper, M. (2010) · Small · doi:10.1002/smll.200902084 · Cited by 263
Toxicity of Nanoparticles on the Reproductive System in Animal Models: A Review
Brohi, R. D., Wang, L., Talpur, H. S., Wu, D., Khan, F. A., Bhattarai, D., Rehman, Z.-U., Farmanullah, F., & Huo, L.-J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00606 · Cited by 259
Reactive oxygen species-related activities of nano-iron metal and nano-iron oxides
Wu, H., Yin, J.-J., Wamer, W. G., Zeng, M., & Lo, Y. M. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.01.007 · Cited by 257
Stepien, G., Moros, M., Pérez-Hernández, M., Monge, M., Gutiérrez, L., Fratila, R. M., las Heras, M. D., Menao Guillén, S., Puente Lanzarote, J. J., Solans, C., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b18648 · Cited by 158
Stem cell tracking using iron oxide nanoparticles
Seifalian, A., Bull, E., Madani, Sheth, Green, M., & Seifalian, A. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s48979 · Cited by 136
Riggio, C., Calatayud, M. P., Giannaccini, M., Sanz, B., Torres, T. E., Fernández-Pacheco, R., Ripoli, A., Ibarra, M. R., Dente, L., Cuschieri, A., et al. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.12.008 · Cited by 112
Refining in vitro models for nanomaterial exposure to cells and tissues
Guggenheim, E. J., Milani, S., Röttgermann, P. J. F., Dusinska, M., Saout, C., Salvati, A., Rädler, J. O., & Lynch, I. (2018) · NanoImpact · doi:10.1016/j.impact.2018.02.008 · Cited by 36
Metadata
- Authors
- Arbab, A. S., Wilson, L. B., Ashari, P., Jordan, E. K., Lewis, B. K., & Frank, J. A.
- Venue
- NMR in Biomedicine
- Publisher
- Wiley
- Published
- 2005-07-13
- Volume
- 18
- Issue
- 6
- Pages
- 383-389
- ISSN
- 0952-3480 (ISSN-L)
- 1099-1492
- OpenAlex
- W2075862824
- Cited by
- 347
- References
- 32
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.